Manufacture of monocyte-derived dendritic cells to stimulate anti-tumor immunity in Phase I trials: the mayo clinic experience
2015
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI